Chronic kidney disease and osteoporosis are major public health problems associated with an aging population. Vitamin K insufficiency is prevalent among patients with end-stage renal disease (ESRD). Preliminary data indicate that poor vitamin K status may compromise bone health and that increased inflammation may be in the causal pathway. We perfor...
Chronic kidney disease and osteoporosis are major public health problems associated with an aging population. Vitamin K insufficiency is prevalent among patients with end-stage renal disease (ESRD). Preliminary data indicate that poor vitamin K status may compromise bone health and that increased inflammation may be in the causal pathway. We perfor...
Chronic kidney disease and osteoporosis are major public health problems associated with an aging population. Vitamin K insufficiency is prevalent among patients with end-stage renal disease (ESRD). Preliminary data indicate that poor vitamin K status may compromise bone health and that increased inflammation may be in the causal pathway. We perfor...
Osteoporosis has remained a leading cause of reduced bone mineral density in post-menopausal women. Raloxifene hydrochloride is a selective oestrogen receptor modulator (SERM) drug which shows beneficial effects in the treatment of osteoporosis. Limited bioavailability of RLX prevents its application as an anti-osteoporotic. The aim of this study w...
Osteoporosis has remained a leading cause of reduced bone mineral density in post-menopausal women. Raloxifene hydrochloride is a selective oestrogen receptor modulator (SERM) drug which shows beneficial effects in the treatment of osteoporosis. Limited bioavailability of RLX prevents its application as an anti-osteoporotic. The aim of this study w...
ASBMR 2018 Annual Meeting, MONTREAL, CANADA, 28-/09/2018 - 01/10/2018
ASBMR 2018 Annual Meeting, MONTREAL, CANADA, 28-/09/2018 - 01/10/2018
ASBMR 2018 Annual Meeting, MONTREAL, CANADA, 28-/09/2018 - 01/10/2018
ASBMR 2018 Annual Meeting, MONTREAL, CANADA, 28-/09/2018 - 01/10/2018
ASBMR 2018 Annual Meeting, MONTREAL, CANADA, 28-/09/2018 - 01/10/2018
